Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial

Hypertension

Volumn 38, Issue 4, 2001, Pages 953-957

  Cushman, William C ^a   Materson, Barry J ^a   Williams, David W ^a   Reda, Domenic J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antihypertensive agents; Drug therapy; Human; Pulse pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CLONIDINE; DILTIAZEM; HYDROCHLOROTHIAZIDE; PLACEBO; PRAZOSIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOSE RESPONSE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POPULATION RESEARCH; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TITRIMETRY;

EID: 0035726188     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1001.096212     Document Type: Conference Paper

References (28)

1. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction
2. Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population
3. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function: SAVE Investigators
4. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension
5. Increased pulse pressure and risk of heart failure in the elderly
6. Is pulse pressure useful in predicting risk for coronary heart disease?: The Framingham Heart study
7. Pulse pressure as a risk factor for cardiovascular events in the MRC mild hypertension trial
8. Pulse pressure: A predictor of cardiovascular mortality among young normotensive subjects
9. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men
10. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC VI)
11. Blood pressure, stroke, and coronary heart disease, part 2: Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
12. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
13. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results if the systolic hypertension in the elderly program (SHEP)
14. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo
15. Department of Veterans Affairs Single-Drug Therapy of Hypertension study: Revised figures and new data
16. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension
17. Drug treatment of hypertension: The reduction of pulse pressure does not necessarily parallel that of systolic and diastolic blood pressure
18. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart study
19. Therapeutic studies and arterial stiffness in hypertension: Recommendations of the European Society of Hypertension, the Clinical Committee of Arterial Structure and Function, Working Group on Vascular Structure and Function of the European Society of Hypertension
20. Results of combination antihypertensive therapy after failure of each of the components
21. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive, Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
22. Treatment of hypertension in the elderly, III: Response of isolated systolic hypertension to various doses of hydrochlorothiazide: Results of a Department of Veterans Affairs Cooperative study
23. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug
24. Treatment of hypertension in the elderly. I: Blood pressure and clinical changes: Results of a Department of Veterans Affairs Cooperative study
25. The role of diastolic blood pressure when treating isolated systolic hypertension
26. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)